Get started Log in

MESO — Mesoblast Share News

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Market Cap
$2.05bn
Enterprise Value
$2.13bn
Revenue
$120.25m

Australia's Mesoblast plunges to record low after discounted placement
05/12/2023 24:47
Brief: Mesoblast To Raise Up To A$97.0 Mln
04/12/2023 04:34
Brief: Mesoblast Seeks Trading Halt
30/11/2023 22:43
Brief: Mesoblast Files For FDA Designations In Congenital Heart Disease
27/11/2023 01:24
Mesoblast up on deal for late-stage trial of GvHD therapy
22/11/2023 12:54
Brief: Mesoblast Partners With Blood And Marrow Transplant Clinical Trials Network
22/11/2023 01:29
Brief: Mesoblast Ltd Says FY Loss Attributable $81.9 Mln
31/08/2023 02:33
Mesoblast Ltd expected to post a loss of 13 cents a share - Earnings Preview
29/08/2023 12:01
U.S.-listed Mesoblast shares slide after US FDA rejects cell therapy for children
04/08/2023 12:57
Mesoblast shares tank after US FDA rejects cell therapy for children (updated)
04/08/2023 05:36
Mesoblast shares slammed on US FDA blow; set for worst session ever
04/08/2023 04:55
FDA rejects Mesoblast's cell therapy for bone marrow transplant complications
04/08/2023 02:57
ASX-listed Mesoblast tanks after US FDA seeks more data for remestemcel-L
04/08/2023 02:27
Brief: Mesoblast Receives Complete Response From U.S. FDA For Biologics License Application For Steroid-Refractory Acute Graft Versus Host Disease In Children
04/08/2023 01:12
Brief: Mesoblast Seeks Trading Halt
01/08/2023 23:43
Australia's Mesoblast gains as quarterly loss narrows
26/05/2023 05:25
Brief: Mesoblast Posts Qtrly Loss After Tax $18.6 Mln
25/05/2023 23:30
Australia's Mesoblast drops most in 10 months on discounted placement
26/04/2023 02:23
Brief: Mesoblast Says Completed Global Private Placement Raising About $40 Mln
26/04/2023 01:43
Brief: Mesoblast Ltd Seeks Trading Halt
20/04/2023 02:00